Bipolar Disorder: Clinical Trials

6 trials for Bipolar Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 withdrawn. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Withdrawn 6
Phase 21Withdrawn 1

Follow Bipolar Disorder: new trials by email Literature Review of Bipolar Disorder trials Research Report on Bipolar Disorder

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder
Ramelteon SL (Dose 1), Ramelteon SL (Dose 2), Placebo - Bipolar Disorder
Phase 3WithdrawnTakeda2012-09-012013-01-23
Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
ziprasidone oral capsules - Bipolar Disorder
Phase 3WithdrawnPfizer's Upjohn has merged with Mylan to form Viatris Inc.2010-07-012021-02-21
Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)
Placebo, Ziprasidone Oral Capsules - Bipolar Disorder
Phase 3WithdrawnPfizer's Upjohn has merged with Mylan to form Viatris Inc.2010-06-012021-02-21
Deep Brain Stimulation (DBS) for Treatment Resistant Bipolar Disorder
DBS Activa PC systems Medtronic, DBS, Activa PC systems Medtronic - Bipolar Disorder
Phase 2 / Phase 3WithdrawnUniversity Hospital, Bonn2010-05-012018-08-07
What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?
Dietary amino-acid depletion - Bipolar Depression
Phase 3WithdrawnUniversity of British Columbia2009-01-012014-07-08
A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
Aripiprazole, Placebo - Bipolar Disorder
Phase 3WithdrawnOtsuka Pharmaceutical Development & Commercialization, Inc.2006-12-012013-11-08

Narrower conditions

Mania (1)

Broader conditions

Bipolar and Related Disorders (6)  ·  Mental Disorders (6)  ·  Mood Disorders (6)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

ziprasidone (2)  ·  Aripiprazole (1)  ·  Deep Brain Stimulation (1)  ·  ramelteon (1)

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (2)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (1)  ·  Takeda (1)  ·  University Hospital, Bonn (1)  ·  University of British Columbia (1)

Countries

Germany (1)  ·  India (1)  ·  United States (1)

Top investigators

Alex Goumeniouk, Ph.D (1)